NCT01684241 2020-01-18
MERIT
BioNTech SE
Phase 1 Completed
Clinical Trials
4 trialsNCT02035956 2020-01-18
IVAC MUTANOME Phase I Clinical Trial
BioNTech SE
Phase 1 Completed
NCT01702792 2018-04-04
Derivation of Tumor Specific Hybridomas
Dartmouth-Hitchcock Medical Center
Phase 1 Terminated
NCT01525017 2015-10-12
A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
Mendus
Phase 1 Completed